Latest Market Sentiment News

Euroz Hartleys Group Limited reported a robust FY2025 with an 87.7% jump in net profit and a strong start to FY2026, driven by increased brokerage and capital markets activity.

QGold Pty Ltd has initiated an unconditional on-market takeover bid for Venus Metals Corporation at $0.17 per share, aiming to consolidate its 26.4% stake by acquiring the remaining shares through a market purchase strategy.

Atomic Eagle Ltd, formerly known as Tombador Iron Limited, will have its trading suspension lifted and be reinstated to quotation on the ASX starting 24 November 2025 after meeting key compliance requirements.

WAM Income Maximiser Limited has confirmed its fully franked ordinary dividend for November 2025 and updated the Dividend Reinvestment Plan price, providing clarity for investors ahead of the payment date.

Embark Early Education has revised the timeline for its conditional takeover bid of Mayfield Childcare, delaying key regulatory filings into early 2026.

Janus Electric Holdings will have its trading suspension lifted on 21 November 2025 following the release of its annual financial report, reopening the stock to market activity.

ALS Limited has announced an ordinary dividend of AUD 0.194 per share for the half-year ending September 2025, accompanied by a fully franked 30% component and a Dividend Reinvestment Plan with no discount.

Klevo Rewards Limited has been granted a crucial two-week extension by the ASX to meet reinstatement conditions and avoid automatic removal from the official list. The new deadline is now 1 December 2025.

Caravel Minerals has withdrawn its recent Strategic Mine Plan Update, urging investors to await the upcoming Definitive Feasibility Study due in early 2026 before making decisions.

Clara Resources has closed its entitlement offer, raising $366,000, with a significant shortfall now set for placement to sophisticated investors. The company aims to strengthen its capital base amid ongoing market challenges.

L1 Long Short Fund Limited reports robust investment returns well above the ASX200 benchmark and announces a shift to quarterly dividends starting December 2025, signaling confidence in sustained growth.

Invex Therapeutics Ltd has had its trading suspension lifted following an announcement of new board and officer appointments, signaling a fresh chapter for the biotech company.